Content Is King
Open in Telegram
One Stop solution for all your social media content needs. Now share top content, without any copyright.
Show more854
Subscribers
No data24 hours
-57 days
-2430 days
Posts Archive
Viral-News-for-the-Day-29-July-2025
Stock market today: Trade setup for Nifty 50, Trump tariffs to Q1 results today; Eight stocks to buy or sell on Tuesday
Procter & Gamble Names Jejurikar as CEO
Ahead of IPO, Aditya Infotech mobilises ₹582 cr from anchor investors
Elon Musk's Starlink Can Have Only 20 Lakh Connections In India
Stocks to Watch Today: IndusInd Bank, Waaree Energies, NTPC Green, KEC, Torrent Pharma, PNC Infra, RPSG Ventures, Monarch Surveyors in focus on 29 July
IndusInd Bank Q1 PAT falls 68% on decline in loans
Nayara Energy moved Delhi HC against Microsoft over suspension of services
Singapore Air Shares Slump as Air India Loss Hits Earnings
Jane Street to argue that retail demand drove its India trades
BPCL, other OMC stocks in focus as Brent Crude surges past $70/barrel
Samsung to Make Tesla AI Chips in Multiyear Texas Deal
#stockmarket #financebaba
#finance #nifty #sensex
#investing
Keywords-for-the-Day-28-July-2025
Stocks to Watch Today: Kotak Bank, CDSL, Balkrishna Ind & others,
in focus on 28 July
Wockhardt shares, rally 5 percent, Zaynich, pan drug resistant infection
Bajaj Finserv, shares rise 2%, Q1 net profit jumps 30% , Rs 2,789 crore,
buy, sell or hold?
Tata Motors, Samvardhana, Bharat Forge, rise, 2%, US European,
Union trade deal
CDSL, shares tumble 2%, Q1 profit falls, EBITDA, margin contracts 960 basis points
Savy Infra and Logistics, shares list, 14% premium, IPO price, NSE Emerge
IDFC First Bank, stock slips, net profit tumbles 32%, brokerages remain neutral
Shriram Finance, shares rise 2% Q1, should you buy, sell or hold?
Kotak Mahindra Bank, shares sink 5%, muted Q1 show,
should you buy, sell, or hold?
Alembic Pharmaceuticals, shares gain, final approval, anticonvulsant drug
